Bondex International Asbestos Exposure: Joint Compound, Trust Claims & Compensation

Bondex International, Inc. became a major defendant in asbestos litigation involving historical joint compound and related Reardon product lines. Federal bankruptcy records state that Republic Powdered Metals acquired The Reardon Company in 1966, continued Reardon products and formulas, and later transferred the Reardon business and liabilities to Bondex in 1972. A Delaware bankruptcy-court estimation opinion states that Bondex continued manufacturing asbestos-containing joint compound until 1977, when it substituted a reformulated non-asbestos product.

Bondex and Specialty Products Holding Corp. filed Chapter 11 cases on May 31, 2010. Their reorganization plan was confirmed in December 2014, and a Section 524(g) asbestos personal-injury trust was established to resolve qualifying current and future claims. The Claims Processing Facility currently states that the Bondex Trust payment percentage increased from 22% to 29.5%, effective January 4, 2024. Eligibility and actual payment depend on the Trust Distribution Procedures, medical proof, exposure evidence and other claim-specific requirements.

🏢 Bondex & Reardon Company History

The corporate history matters because asbestos claims may involve products manufactured before or after the Bondex entity was formed. Federal court and bankruptcy records connect The Reardon Company, Republic Powdered Metals, RPM and Bondex through a series of acquisitions and internal restructurings.

Bondex Facts at a Glance

Topic	Verified information
Historical product line	Bondex/Reardon joint compound and related building products.
Reardon acquisition	Republic Powdered Metals acquired Reardon in 1966.
RPM name change	Republic Powdered Metals changed its name to RPM, Inc. in 1971.
Bondex formation / transfer	Bondex International was formed as an RPM subsidiary and acquired the Reardon division in 1972.
Asbestos-containing joint compound	Bankruptcy court found Bondex continued manufacturing it until 1977.
Chapter 11 filing	May 31, 2010 for Bondex and SPHC.
Plan effective date	December 23, 2014.
Current trust route	Bondex Asbestos Personal Injury Trust / SPHC Trust procedures.
Current published payment percentage	29.5%, effective January 4, 2024, per Claims Processing Facility.

Corporate Timeline

Period	Documented development
Pre-1966	The Reardon Company manufactured and sold building-product lines later associated with Bondex claims.
1966	Republic Powdered Metals acquired Reardon and operated it as a division.
1971	Republic Powdered Metals changed its name to RPM, Inc.
1972	Bondex International was formed; Reardon assets and liabilities were transferred to Bondex.
1977	Bondex stopped manufacturing asbestos-containing joint compound and substituted a reformulated non-asbestos product, according to the bankruptcy estimation opinion.
1981 onward	Asbestos bodily-injury litigation involving Reardon/RPM/Bondex products began and expanded.
May 31, 2010	Bondex and SPHC filed Chapter 11 cases in Delaware.
Dec. 2014	Reorganization plan confirmed; plan became effective December 23, 2014.
Jan. 4, 2024	Bondex Trust payment percentage increased to 29.5%.

See Construction Materials Companies & Asbestos Exposure.

🧱 Bondex Asbestos Joint Compound & Products

The strongest company-specific evidence concerns Bondex joint compound. The Delaware bankruptcy court stated that Bondex continued to manufacture asbestos-containing joint compound until 1977. Published appellate decisions likewise describe asbestos-containing Bondex joint compound used in drywall installation and home repair. Product identity and date remain important because later reformulated Bondex joint compound was asbestos-free.

Product Evidence

Product / issue	Evidence-based treatment
Bondex joint compound	Documented in bankruptcy and appellate court records as an asbestos-containing historical product.
Dry-mix compound	Court testimony describes powdered compound mixed with water, applied and sanded after drying.
Reardon product lines	May be relevant under the trust depending on product, dates and liability criteria.
Post-1977 Bondex joint compound	Do not assume asbestos content; bankruptcy record states a non-asbestos reformulation replaced the asbestos-containing product in 1977.
Other patching / finishing products	Must be confirmed through the Trust’s official product information or other primary records before attributing asbestos content.

Product Accuracy Rules

Statement	Accurate treatment
Bondex historically made asbestos-containing joint compound	Supported by federal bankruptcy and court records.
Every Bondex product contained asbestos	Not supported.
Every Bondex joint compound made in every year contained asbestos	Not supported; 1977 reformulation is specifically documented.
Dust from mixing or sanding historical compound was alleged as exposure	Supported by published case records.
A Bondex label alone proves a compensable trust claim	No; exposure, medical and TDP requirements must be satisfied.

👷 Workers, Jobsites & DIY Bondex Exposure

Bondex joint compound was used in drywall finishing and repair. Court records describe professional construction exposure as well as do-it-yourself home repair. The relevant exposure investigation focuses on whether a claimant mixed, applied, sanded, swept or worked near historical asbestos-containing Bondex compound.

Workers and Activities to Investigate

Worker / person	Potential historical activity
Drywall finishers / tapers	Mixing dry compound, applying it to seams and sanding dried surfaces.
Carpenters	Working near tapers or performing repair and patching work.
Painters / remodelers	Surface preparation and renovation involving old compound.
Construction laborers	Cleanup and sweeping after sanding.
Maintenance workers	Repairing walls and ceilings.
Homeowners / DIY renovators	Mixing and sanding Bondex compound during home projects.
Family / household members	Potential secondary exposure requires claimant-specific proof under applicable trust criteria.

Documented Exposure Settings

Setting	Court-record example
Residential construction	Dori litigation described Bondex joint compound used in custom-home work.
Home repair	Saller litigation described personal use of Bondex joint compound for home repair.
Federal buildings	Anderson litigation involved alleged joint-compound exposure in federal buildings.
Construction sites	Wagner litigation described Bondex joint compound used during drywall installation.
Home construction in Utah	Larson litigation involved asbestos-containing joint compounds used while building homes.

Need help now? Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Submit Your Case

🌫️ How Historical Bondex Asbestos Exposure Occurred

Historical joint compound was commonly worked as a dry or wet material and later sanded to create a smooth wall surface. Court records specifically describe dust during mixing and sanding. Whether a particular task created compensable exposure depends on the product, date, frequency, proximity and claimant-specific evidence.

Potential Exposure Activities

Activity	Potential exposure mechanism
Opening dry compound	Handling powdered material could release dust.
Mixing with water	Pouring and mixing dry powder could create airborne dust.
Applying compound	Wet application generally differs from dry sanding in dust generation.
Sanding dried compound	Court records repeatedly identify sanding as a dusty activity.
Sweeping / cleanup	Could re-suspend settled construction dust.
Renovation / demolition	Disturbing old finished surfaces may involve multiple historical materials; product identification remains necessary.

Exposure Questions That Matter

Question	Why it matters
Was the product actually Bondex or a Reardon product?	Establishes product identity.
When was it purchased or used?	Helps distinguish historical asbestos formulations from later non-asbestos products.
Was it dry-mix or another formulation?	Clarifies work process and evidence.
Was the claimant mixing, sanding or nearby?	Establishes the alleged exposure pathway.
How often did the work occur?	Frequency and duration can matter under legal and trust standards.
Are boxes, invoices, witnesses or job records available?	Corroborates exposure history.

⚖️ Bondex Asbestos Trust & Claims

Bondex and SPHC entered Chapter 11 to resolve asbestos liabilities. SEC filings state that the confirmed plan established Section 524(g) trusts and transferred responsibility for qualifying present and future asbestos personal-injury claims to the trust structure. The Claims Processing Facility administers Bondex claim materials and publishes the Trust Distribution Procedures.

Bondex Trust Facts

Trust fact	Confirmed information
Chapter 11 filing	Bondex and SPHC filed May 31, 2010.
Plan confirmation	December 10, 2014.
Effective date	December 23, 2014.
Initial cash contribution	$450 million to the combined trust structure at effectiveness, according to RPM SEC filings.
Additional scheduled contributions	$102.5 million, $120 million and $125 million under the confirmed funding structure.
Total scheduled contributions	$797.5 million based on the four stated contributions; this is historical funding, not a current trust balance.
Bondex payment percentage	29.5%, effective January 4, 2024, according to CPF.
Claims administrator	Claims Processing Facility, Inc. (CPF).
Claim documentation	Medical documentation plus proof of exposure to asbestos-containing products for which an SPHC Party has liability.

Payment Percentage: How to Read It

Item	Explanation
29.5%	CPF’s currently published Bondex payment percentage, effective Jan. 4, 2024.
Purpose	A payment percentage helps preserve assets for present and future qualifying claimants.
Not a guaranteed award	The percentage is applied only after a claim is allowed and liquidated under applicable procedures.
Can change	Trustees may adjust the percentage under the TDP; verify the official CPF notice when filing.
Not an average settlement	Do not divide historical funding or aggregate claims to estimate an individual payment.

Claim Filing Requirements

Requirement	Official CPF guidance
Claim form	Complete the standardized Bondex claim form or use authorized electronic filing.
Medical proof	Submit valid medical documentation supporting the alleged injury.
Exposure proof	Submit documentation establishing exposure to asbestos-containing products for which an SPHC Party has liability.
Deadline	Claim must satisfy the applicable filing deadline in TDP Section 5.1(a)(2).
Certification	Claimant/representative must certify the accuracy of submitted allegations.
Review	Claims are processed under the TDP and applicable review procedures.

Trust values and payment percentages can change. The 29.5% figure above is tied to CPF’s official January 2024 notice. Claimants should confirm the current official TDP and payment notice when filing.

📊 Documented Bondex Asbestos Cases

Published decisions provide unusually strong company-specific evidence for Bondex. They document historical joint compound use, dusty mixing and sanding activities, asbestos-related disease allegations and the importance of proving exposure and causation in each individual case.

Selected Court and Bankruptcy Records

Record	Documented significance
SPHC/Bondex bankruptcy estimation opinion, D. Del. (2013)	Describes Reardon/RPM/Bondex corporate history and states Bondex continued asbestos-containing joint compound until 1977.
Dori v. Bondex International, Texas Ct. App. (2006)	Mesothelioma claim involving Bondex Joint Compound; testimony described powder mixed with water and sanding dust. Take-nothing judgment affirmed.
Saller v. Crown Cork & Seal, California Ct. App. (2010)	Wrongful-death litigation included personal use of Bondex joint compound during home repair; appellate court reversed on instructional issues.
Wagner v. Bondex International, Missouri Ct. App. (2012)	Court stated Bondex joint compound contained asbestos from 1961 to 1977 and discussed construction-site exposure.
Anderson, E.D. Pa. MDL 875 (2010)	Mesothelioma case involving alleged joint-compound exposure in federal buildings; illustrates jurisdiction and exposure issues.
Bondex v. Hartford, Sixth Circuit	Insurance litigation documented thousands of asbestos suits and Reardon/RPM/Bondex corporate history.

What These Cases Establish—and What They Do Not

Evidence	Proper interpretation
Historical asbestos-containing Bondex joint compound	Strongly documented.
Dust from mixing/sanding	Documented in claimant testimony and case records.
Asbestos use through 1977	Supported by bankruptcy and appellate records.
Every Bondex-branded product contained asbestos	Not established.
Every person who used Bondex qualifies for compensation	Not established.
Any specific payment amount	Must be determined under current trust procedures and claimant evidence.

📋 Bondex Claim Evidence & Product Identification

A strong Bondex exposure history identifies the product, approximate date, work activity and location, then connects those facts to medical documentation. The official CPF claim instructions specifically require medical documentation and exposure documentation.

Evidence That May Help

Medical and pathology records documenting an asbestos-related disease.
Employment, union, Social Security or contractor records.
Bondex or Reardon product boxes, photographs, labels or receipts.
Invoices, purchase orders and building-material records.
Construction contracts, job files and renovation records.
Coworker, contractor or family-member testimony.
Evidence describing mixing, application, sanding and cleanup.
Dates showing use during the documented asbestos-product period.
Official CPF product/exposure materials applicable to the claim.

Claim Investigation Checklist

Step	Question
1	Was Bondex/Reardon product use specifically identified?
2	What exact product or product type was involved?
3	When and where was it used?
4	Was the product mixed, sanded, swept or otherwise disturbed?
5	How frequently and closely was the claimant exposed?
6	Can another witness or record corroborate the product?
7	Does medical documentation satisfy the TDP disease criteria?
8	Does exposure documentation satisfy the applicable Bondex/SPHC criteria?
9	Has the current CPF payment percentage and filing deadline been checked?

Numbers We Do Not Invent

Item	Treatment
Current trust assets	Do not equate historical $797.5 million scheduled funding with today’s balance.
Average Bondex payout	Not calculated from aggregate funding.
Claim approval rate	Not stated without a current official trust report.
Individual settlement value	Depends on allowed/liquidated claim value and current payment percentage.
Exposure level for a specific person	Requires claimant-specific evidence.
Guaranteed compensation	None.

Compensation is not guaranteed. Eligibility and payment depend on diagnosis, product identification, exposure evidence, TDP requirements, deadlines and the Trust’s review.

❓ Frequently Asked Questions

Did Bondex manufacture asbestos-containing joint compound?

Yes. Federal bankruptcy and appellate court records document historical Bondex asbestos-containing joint compound. The bankruptcy estimation opinion states Bondex continued manufacturing it until 1977.

When did Bondex stop making asbestos-containing joint compound?

The Delaware bankruptcy-court estimation opinion states that in 1977 Bondex substituted a reformulated product that did not contain asbestos.

How could workers have been exposed to Bondex asbestos?

Court records describe dry joint compound being mixed with water and later sanded. Mixing, sanding and cleanup were alleged to create dust exposure.

Does Bondex have an asbestos trust?

Yes. The confirmed reorganization established a Section 524(g) trust structure for qualifying Bondex/SPHC asbestos personal-injury claims.

What is the Bondex Trust payment percentage?

The Claims Processing Facility states that the Bondex Trust payment percentage increased from 22% to 29.5%, effective January 4, 2024. The current official notice should be checked when filing because percentages can change.

How much was the trust funded with?

RPM’s SEC filings describe $450 million at effectiveness plus scheduled additional contributions of $102.5 million, $120 million and $125 million. Together those scheduled contributions total $797.5 million. That historical funding figure is not the same as the trust’s current assets.

What evidence is needed for a Bondex trust claim?

CPF states that valid medical documentation and documentation establishing exposure to asbestos-containing products for which an SPHC Party has liability must accompany the claim, along with the required claim form and certification.

Does using a Bondex product guarantee compensation?

No. A claimant must satisfy the applicable medical, exposure, filing and other Trust Distribution Procedure requirements. Product use alone does not guarantee an allowed claim or payment.

🧾 Bondex International Asbestos Summary

Detail	Confirmed / carefully qualified information
Historical asbestos product	Bondex joint compound.
Documented asbestos period	Bankruptcy record states manufacture continued until 1977; Missouri appellate record describes 1961–1977.
Corporate lineage	Reardon → Republic Powdered Metals/RPM → Bondex.
Chapter 11 filing	May 31, 2010.
Plan effective	December 23, 2014.
Historical scheduled trust funding	$797.5 million total from stated contributions; not current assets.
Current published payment percentage	29.5%, effective January 4, 2024, per CPF.
Claim administrator	Claims Processing Facility.
Guaranteed compensation	No.

📚 Confirmed Primary & Court Sources

Submit Your Case

Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Submit Your Case

Historical use of a Bondex or Reardon product does not automatically establish asbestos exposure, disease causation, trust eligibility or compensation. Product identity, dates, work activity, medical evidence and the current Trust Distribution Procedures must be evaluated individually. Compensation is not guaranteed.

⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not legal or medical advice. Consult a qualified healthcare professional about diagnosis and treatment and a qualified attorney about individual legal rights, trust requirements and filing deadlines.